W. Michael Scheld

6.2k total citations · 2 hit papers
92 papers, 4.6k citations indexed

About

W. Michael Scheld is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, W. Michael Scheld has authored 92 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Epidemiology, 47 papers in Microbiology and 26 papers in Infectious Diseases. Recurrent topics in W. Michael Scheld's work include Bacterial Infections and Vaccines (47 papers), Pneumonia and Respiratory Infections (25 papers) and Antibiotics Pharmacokinetics and Efficacy (18 papers). W. Michael Scheld is often cited by papers focused on Bacterial Infections and Vaccines (47 papers), Pneumonia and Respiratory Infections (25 papers) and Antibiotics Pharmacokinetics and Efficacy (18 papers). W. Michael Scheld collaborates with scholars based in United States, Switzerland and France. W. Michael Scheld's co-authors include Gregory C. Townsend, Merle A. Sande, Allan R. Tunkel, Vincent Quagliarello, Brian Wispelwey, James A. Valone, Richard Calderone, John E. Edwards, Charles M. van der Horst and John Rex and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Investigation.

In The Last Decade

W. Michael Scheld

91 papers receiving 4.3k citations

Hit Papers

A Randomized Trial Comparing Fluconazole with Amphoterici... 1991 2026 2002 2014 1994 1991 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Michael Scheld United States 32 2.0k 1.6k 1.2k 645 644 92 4.6k
Martin G. Täuber Switzerland 39 2.0k 1.0× 907 0.6× 1.9k 1.5× 539 0.8× 600 0.9× 108 4.5k
Helmut Eiffert Germany 35 1.2k 0.6× 1.5k 1.0× 702 0.6× 474 0.7× 347 0.5× 115 4.5k
Kurt Olsen United States 33 2.3k 1.1× 497 0.3× 1.9k 1.5× 503 0.8× 405 0.6× 56 4.0k
W. Michael Scheld United States 40 3.8k 1.9× 1.6k 1.0× 2.9k 2.4× 1.2k 1.8× 1.0k 1.6× 102 8.6k
Gerald L. Mandell United States 41 1.5k 0.7× 1.7k 1.1× 405 0.3× 563 0.9× 691 1.1× 129 6.0k
Carmen Cabellos Spain 29 1.8k 0.9× 725 0.5× 1.3k 1.1× 438 0.7× 600 0.9× 84 3.2k
O. Zák Switzerland 30 1.1k 0.5× 520 0.3× 901 0.7× 303 0.5× 577 0.9× 71 2.9k
Allan R. Tunkel United States 32 4.2k 2.1× 1.8k 1.1× 4.1k 3.3× 1.5k 2.3× 510 0.8× 91 7.7k
Rodrigo Hasbun United States 32 2.5k 1.2× 1.6k 1.0× 1.7k 1.4× 997 1.5× 225 0.3× 152 4.5k
Tetsuya Matsumoto Japan 39 1.2k 0.6× 954 0.6× 551 0.4× 309 0.5× 376 0.6× 271 5.7k

Countries citing papers authored by W. Michael Scheld

Since Specialization
Citations

This map shows the geographic impact of W. Michael Scheld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Michael Scheld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Michael Scheld more than expected).

Fields of papers citing papers by W. Michael Scheld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Michael Scheld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Michael Scheld. The network helps show where W. Michael Scheld may publish in the future.

Co-authorship network of co-authors of W. Michael Scheld

This figure shows the co-authorship network connecting the top 25 collaborators of W. Michael Scheld. A scholar is included among the top collaborators of W. Michael Scheld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Michael Scheld. W. Michael Scheld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Drancourt, Michel, Vanessa Demonfort Nkamga, Ndèye Aïssatou Lakhe, et al.. (2017). Evidence of Archaeal Methanogens in Brain Abscess. Clinical Infectious Diseases. 65(1). 1–5. 50 indexed citations
2.
Sable, Carole A. & W. Michael Scheld. (2015). Theoretical and Practical Considerations of Antibiotic Therapy for Bacterial Meningitis. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 45. 96–117.
3.
Moore, Christopher C., et al.. (2014). Toll-Like Receptor 4 Stimulation before or after Streptococcus pneumoniae Induced Sepsis Improves Survival and Is Dependent on T-Cells. PLoS ONE. 9(1). e86015–e86015. 11 indexed citations
5.
Tessier, Jeffrey M. & W. Michael Scheld. (2010). Principles of antimicrobial therapy. Handbook of clinical neurology. 96. 17–29. 11 indexed citations
6.
Hedrick, Traci L., Shannon T. McElearney, Robert L. Smith, et al.. (2008). Outbreak of Resistant Pseudomonas aeruginosa Infections during a Quarterly Cycling Antibiotic Regimen. Surgical Infections. 9(2). 139–152. 23 indexed citations
7.
Smith, Robert L., Heather L. Evans, Tae W. Chong, et al.. (2008). Reduction in Rates of Methicillin-Resistant Staphylococcus aureus Infection after Introduction of Quarterly Linezolid–Vancomycin Cycling in a Surgical Intensive Care Unit. Surgical Infections. 9(4). 423–431. 20 indexed citations
9.
Tunkel, Allan R. & W. Michael Scheld. (2002). Treatment of bacterial meningitis. Current Infectious Disease Reports. 4(1). 7–16. 18 indexed citations
10.
Townsend, Gregory C. & W. Michael Scheld. (1993). Adjunctive Therapy for Bacterial Meningitis: Rationale for Use, Current Status, and Prospects for the Future. Clinical Infectious Diseases. 17(Supplement_2). S537–S549. 27 indexed citations
11.
Scheld, W. Michael, Marc Whitman, & Allan R. Tunkel. (1992). Azithromycin and Clarithromycin Overview and Comparison With Erythromycin. Infection Control and Hospital Epidemiology. 13(6). 357–368. 84 indexed citations
12.
Tunkel, Allan R., et al.. (1992). Enterobacter Endocarditis. Scandinavian Journal of Infectious Diseases. 24(2). 233–240. 13 indexed citations
13.
Tunkel, Allan R., Brian Wispelwey, Vincent Quagliarello, et al.. (1992). Pathophysiology of Blood-Brain Barrier Alterations during Experimental Haemophilus influenzae Meningitis. The Journal of Infectious Diseases. 165(Supplement 1). S119–S120. 11 indexed citations
14.
Quagliarello, Vincent, et al.. (1991). Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor.. Journal of Clinical Investigation. 87(4). 1360–1366. 318 indexed citations
15.
Tunkel, Allan R., et al.. (1991). Blood-brain barrier alterations in bacterial meningitis: Development of an in vitro model and observations on the effects of lipopolysaccharide. In Vitro Cellular & Developmental Biology - Animal. 27(2). 113–120. 47 indexed citations
16.
Sande, Merle A., et al.. (1989). Pathophysiology of bacterial meningitis. The Pediatric Infectious Disease Journal. 8(12). 929–934. 18 indexed citations
17.
Tunkel, Allan R. & W. Michael Scheld. (1989). Alterations of the blood-brain barrier in bacterial meningitis. The Pediatric Infectious Disease Journal. 8(12). 911–912. 12 indexed citations
18.
Lesse, Alan J., E. Richard Moxon, A Zwahlen, & W. Michael Scheld. (1988). Role of cerebrospinal fluid pleocytosis and Haemophilus influenzae type b capsule on blood brain barrier permeability during experimental meningitis in the rat.. Journal of Clinical Investigation. 82(1). 102–109. 24 indexed citations
19.
Wispelwey, Brian & W. Michael Scheld. (1987). Brain Abscess. Clinical Neuropharmacology. 10(6). 483–510. 12 indexed citations
20.
Scheld, W. Michael, et al.. (1979). Pulmonary infection with capsule-deficientCryptococcus neoformans. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 382(1). 113–118. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026